The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya

The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya

Veure altres versions (1)

Backgound: Sulphadoxine/sulphalene-pyrimethamine (SP) was adopted in Kenya as first line therapeutic for uncomplicated malaria in 1998. By the second half of 2003, there was convincing evidence that SP was failing and had to be replaced. Despite several descriptive investigations of policy change an...

Descripció completa

Dades bibliogràfiques
Autors principals:	Amin, A, Zurovac, D, Kangwana, B, Greeenfield, J, Otieno, D, Akhwale, W, Snow, R
Format:	Journal article
Idioma:	English
Publicat:	BioMed Central 2007
Matèries:	Malaria Tropical medicine Infectious diseases

Ítems similars

The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya.
per: Amin, A, et al.
Publicat: (2007)

The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya
per: Otieno Dorothy N, et al.
Publicat: (2007-05-01)

The decline in paediatric malaria admissions on the coast of Kenya
per: Okiro, E, et al.
Publicat: (2007)

Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
per: Zurovac, D, et al.
Publicat: (2007)

Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine
per: Wasunna, B, et al.
Publicat: (2008)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia
per: Sipilanyambe, N, et al.
Publicat: (2008)

Brands, costs and registration status of antimalarial drugs in the Kenyan retail sector
per: Amin, A, et al.
Publicat: (2005)

Malaria early warning in Kenya
per: Hay, S, et al.
Publicat: (2001)

Evidence for over-dispersion in the distribution of clinical malaria episodes in children
per: Mwangi, T, et al.
Publicat: (2008)

Defining equity in physical access to clinical services using geographical information systems as part of malaria planning and monitoring in Kenya
per: Noor, A, et al.
Publicat: (2003)

Assembling a global database of malaria parasite prevalence for the Malaria Atlas Project
per: Guerra, C, et al.
Publicat: (2007)

Distribution of the main malaria vectors in Kenya
per: Okara, R, et al.
Publicat: (2010)

The haptoglobin 2-2 genotype is associated with a reduced incidence of Plasmodium falciparum malaria in children on the coast of Kenya
per: Atkinson, S, et al.
Publicat: (2007)

The risks of malaria infection in Kenya in 2009
per: Noor, A, et al.
Publicat: (2009)

Molecular pathological investigation of the pathophysiology of fatal malaria
per: Prapansilp, P
Publicat: (2012)

Access and barriers to measures targeted to prevent malaria in pregnancy in rural Kenya
per: Gikandi, P, et al.
Publicat: (2008)

Artemisinin antimalarials: preserving the "magic bullet"
per: Maude, R, et al.
Publicat: (2010)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda
per: Zurovac, D, et al.
Publicat: (2008)

The Activity of Mixed Microalgae Polysaccharides from Indonesia as Anti-Malaria in Vitro
per: Mahendra Pujiyanto, et al.
Publicat: (2022-08-01)

The relationship between the Plasmodium falciparum parasite ratio in childhood and climate estimates of malaria transmission in Kenya
per: Omumbo, J, et al.
Publicat: (2004)

Standardizing estimates of the Plasmodium falciparum parasite rate
per: Smith, D, et al.
Publicat: (2007)

Morbidity and mortality due to Plasmodium vivax malaria in Papua, Indonesia and its control using antimalarial drugs
per: Douglas, N
Publicat: (2011)

The co-distribution of Plasmodium falciparum and hookworm among African schoolchildren
per: Brooker, S, et al.
Publicat: (2006)

Increasing coverage and decreasing inequity in insecticide-treated bed net use among rural Kenyan children
per: Noor, A, et al.
Publicat: (2007)

Plasmodium infection and its risk factors in eastern Uganda
per: Pullan, R, et al.
Publicat: (2010)

Pharmacokinetics and pharmacodynamics of antimalarial drugs in pregnant women
per: Kloprogge, F
Publicat: (2013)

Ranking of elimination feasibility between malaria-endemic countries
per: Tatem, A, et al.
Publicat: (2010)

Health facility and health worker readiness to deliver new national treatment policy for malaria in Kenya.
per: Njogu, J, et al.
Publicat: (2008)

Barriers to prompt and effective malaria treatment among the poorest population in Kenya
per: Chuma, J, et al.
Publicat: (2010)

The uncertain burden of Plasmodium falciparum epidemics in Africa
per: Cox, J, et al.
Publicat: (2007)

Malaria in Africa: progress and prospects in the decade since the Abuja Declaration
per: Snow, R, et al.
Publicat: (2010)

An immune basis for malaria protection by the sickle cell trait
per: Williams, T, et al.
Publicat: (2005)

Information for decision making from imperfect national data: tracking major changes in health care use in Kenya using geostatistics
per: Gething, P, et al.
Publicat: (2007)

Revisiting the basic reproductive number for malaria and its implications for malaria control
per: Smith, D, et al.
Publicat: (2007)

Wealth, mother's education and physical access as determinants of retail sector net use in rural Kenya
per: Noor, A, et al.
Publicat: (2006)

Mapping the global extent of malaria in 2005
per: Guerra, C, et al.
Publicat: (2006)

Strategies for improving radical cure in P. vivax malaria
per: John, G
Publicat: (2012)

The financial and clinical implications of adult malaria diagnosis using microscopy in Kenya.
per: Zurovac, D, et al.
Publicat: (2006)

Spread of anti-malarial drug resistance: Mathematical model with implications for ACT drug policies
per: Pongtavornpinyo, W, et al.
Publicat: (2008)

Measuring malaria endemicity from intense to interrupted transmission
per: Hay, S, et al.
Publicat: (2008)